Cargando…

Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger’s disease) exacerbation

Detalles Bibliográficos
Autores principales:	Darnige, L, Helley, D, Fischer, AM, Emmerich, J, Smadja, DM, Fiessinger, JN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837587/ https://www.ncbi.nlm.nih.gov/pubmed/19818096 http://dx.doi.org/10.1111/j.1582-4934.2009.00928.x

Ejemplares similares

Thromboangiitis obliterans (Buerger's disease)
por: Arkkila, Perttu ET
Publicado: (2006)

Thromboangiitis obliterans (Buerger's disease)
por: Rivera-Chavarría, Ignacio J., et al.
Publicado: (2016)

Thromboangiitis Obliterans (Buerger's Disease)
por: Sinclair, Nicholas R., et al.
Publicado: (2015)

Thromboangiitis obliterans (Buerger disease)
por: Seebald, Jessica, et al.
Publicado: (2015)

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan
por: De Haro, Joaquin, et al.
Publicado: (2012)

Thromboangiitis Obliterans (Buerger's Disease)—Current Practices
por: Vijayakumar, Abhishek, et al.
Publicado: (2013)

The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans)
por: Beigi, Ali Akbar, et al.
Publicado: (2014)

Retinal Artery Occlusion Secondary to Buerger's Disease (Thromboangiitis Obliterans)
por: Eris, Erdem, et al.
Publicado: (2017)

Buerger's Disease in the Testicle: A Case of Testicular Thromboangiitis Obliterans
por: Harwood, Emma A, et al.
Publicado: (2023)

The Imbalance among Oxidative Biomarkers and Antioxidant Defense Systems in Thromboangiitis Obliterans (Winiwarter-Buerger Disease)
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Buerger's disease (thromboangiitis obliterans): clinical features and assessment by colour duplex ultrasound
por: Busch, Kathryn
Publicado: (2015)

Thromboangiitis Obliterans
Publicado: (1953)

Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
por: Le Joncour, Alexandre, et al.
Publicado: (2018)

Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature
por: Narváez, Javier, et al.
Publicado: (2016)

Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)
por: Martin-Rufino, Jorge D., et al.
Publicado: (2018)

Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences
por: Fazeli, Bahare, et al.
Publicado: (2021)

Thromboangiitis obliterans in two brothers
por: LI, QI-LIN, et al.
Publicado: (2013)

Long-term outcomes of large artery thromboangiitis obliterans and comparison with small artery thromboangiitis obliterans
por: Lee, Sang Ah, et al.
Publicado: (2022)

Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study
por: Marwah, Vikram
Publicado: (2012)

Circulating Angiogenic Factors in Patients with Thromboangiitis Obliterans
por: Hewing, Bernd, et al.
Publicado: (2012)

Intestinal thromboangiitis obliterans: a case report
por: Mishra, Swastik Sourav, et al.
Publicado: (2021)

Thromboangiitis Obliterans: Changing Demographics for a Preventable Disease
por: Stefancik, Ryan
Publicado: (2019)

Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?
por: Mohareri, Mehran, et al.
Publicado: (2018)

Assessment of T helper 17-associated cytokines in thromboangiitis obliterans
por: Keramat, Shayan, et al.
Publicado: (2019)

Cerebral venous and sinus thrombosis with complicating thromboangiitis obliterans
por: Einsiedler, Stefan, et al.
Publicado: (2021)

Clinical Presentation and Treatment of Thromboangiitis Obliterans With Superimposed Osteomyelitis
por: Kidron, Ariel, et al.
Publicado: (2022)

Thromboangiitis Obliterans: 110 Years Old and Little Progress Made
por: Olin, Jeffrey W.
Publicado: (2018)

Visceral bed involvement in thromboangiitis obliterans: a systematic review
por: Fakour, Faeze, et al.
Publicado: (2019)

Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients
por: Yong, Jun, et al.
Publicado: (2018)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study
por: Kulkarni, Sunil, et al.
Publicado: (2011)

Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans
por: Wu, Shifeng, et al.
Publicado: (2018)

Psychiatric sequelae of thromboangiitis obliterans: a case report and review of the literature
por: Awara, Mahmoud A., et al.
Publicado: (2023)

Early Diagnosis and Intervention Are Needed for a Reasonable Prognosis of Thromboangiitis Obliterans
por: Bae, Miju, et al.
Publicado: (2023)

End stage renal disease caused by thromboangiitis obliterans: a case report
por: Yun, Hyo-Jin, et al.
Publicado: (2015)

Treatment of multiple refractory ankle ulcerations in thromboangiitis obliterans: A case report
por: Huang, Zheng-Hao, et al.
Publicado: (2018)

Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review
por: Shapouri-Moghaddam, Abbas, et al.
Publicado: (2019)

A Rare Case of Thromboangiitis Obliterans of Bilateral Upper Extremities in an Adult Male
por: Ejiyooye, Toluwalope F, et al.
Publicado: (2022)

Atypical Young-onset Dementia in Cerebral Thromboangiitis Obliterans: A Case Report
por: Kim, Eun-Joo, et al.
Publicado: (2022)

Homozygous Factor V Leiden Thrombophilia in a Patient With Histologically Confirmed Thromboangiitis Obliterans
por: Mensa, Mussa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u68ijccu0k9qlrie9fj5maeglm